2020 ended with an inoculated bang. Despite renewed lockdowns in Europe and rising COVID-19 infections globally, risk assets continued their march upwards. This was amid hopes for reflation, better growth and higher earnings, supported by a backdrop of more fiscal stimulus in the US, a Brexit deal and the beginnings of vaccine rollouts.